Citation: Fj. Koppenhagen et al., DEVELOPMENT OF A ROUTINE ANALYSIS METHOD FOR LIPOSOME-ENCAPSULATED RECOMBINANT INTERLEUKIN-2, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 285-291
Authors:
REUBSAET JLE
BEIJNEN JH
BULT A
HOP E
SCHOLTEN SD
TEEUWSEN J
UNDERBERG WJM
Citation: Jle. Reubsaet et al., OXIDATION OF RECOMBINANT METHIONYL HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of pharmaceutical and biomedical analysis, 17(2), 1998, pp. 283-289
Authors:
HOITINK MA
BEIJNEN JH
BOSCHMA MUS
BULT A
VANDERHOUWEN OAGJ
WIESE G
UNDERBERG WJM
Citation: Ma. Hoitink et al., DEGRADATION KINETICS OF 3 GONADORELIN ANALOGS - DEVELOPING A METHOD FOR CALCULATING EPIMERIZATION PARAMETERS, Pharmaceutical research, 15(9), 1998, pp. 1449-1455
Authors:
VANDEWETERING P
ZUIDAM NJ
VANSTEENBERGEN MJ
VANDERHOUWEN OAGJ
UNDERBERG WJM
HENNINK WE
Citation: P. Vandewetering et al., A MECHANISTIC STUDY OF THE HYDROLYTIC STABILITY OF POLY(2-(DIMETHYLAMINO)ETHYL METHACRYLATE), Macromolecules, 31(23), 1998, pp. 8063-8068
Authors:
HOITINK MA
HOP E
BEIJNEN JH
BULT A
KETTENESVANDENBOSCH JJ
UNDERBERG WJM
Citation: Ma. Hoitink et al., CAPILLARY ZONE ELECTROPHORESIS MASS-SPECTROMETRY AS A TOOL IN THE STABILITY RESEARCH OF THE LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG GOSERELIN, Journal of chromatography, 776(2), 1997, pp. 319-327
Authors:
KAIJSER GP
BEIJNEN JH
BULT A
KEIZER HJ
UNDERBERG WJM
Citation: Gp. Kaijser et al., CHROMATOGRAPHIC ANALYSIS OF THE ENANTIOMERS OF IFOSFAMIDE AND SOME OFITS METABOLITES IN PLASMA AND URINE, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 131-138
Authors:
KAIJSER GP
TERRIET PGJH
DEKRAKER J
BULT A
BEIJNEN JH
UNDERBERG WJM
Citation: Gp. Kaijser et al., DETERMINATION OF 4-HYDROXYIFOSFAMIDE IN BIOLOGICAL MATRICES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 15(6), 1997, pp. 773-781
Citation: Oagj. Vanderhouwen et al., SYSTEMATIC INTERPRETATION OF PH-DEGRADATION PROFILES - A CRITICAL-REVIEW, International journal of pharmaceutics, 155(2), 1997, pp. 137-152
Authors:
BARDELMEIJER HA
WATERVAL JCM
LINGEMAN H
VANTHOF R
BULT A
UNDERBERG WJM
Citation: Ha. Bardelmeijer et al., PRE-COLUMN, ON-COLUMN AND POSTCOLUMN DERIVATIZATION IN CAPILLARY ELECTROPHORESIS, Electrophoresis, 18(12-13), 1997, pp. 2214-2227
Authors:
VANDIJKWOLTHUIS WNE
VANSTEENBERGEN MJ
UNDERBERG WJM
HENNINK WE
Citation: Wne. Vandijkwolthuis et al., DEGRADATION KINETICS CF METHACRYLATED DEXTRANS IN AQUEOUS-SOLUTION, Journal of pharmaceutical sciences, 86(4), 1997, pp. 413-417
Authors:
HOITINK MA
BEIJNEN JH
BOSCHMA MUS
BULT A
HOP E
NIJHOLT J
VERSLUIS C
WIESE G
UNDERBERG WJM
Citation: Ma. Hoitink et al., IDENTIFICATION OF THE DEGRADATION PRODUCTS OF GONADORELIN AND 3 ANALOGS IN AQUEOUS-SOLUTION, Analytical chemistry, 69(24), 1997, pp. 4972-4978
Authors:
KAIJSER GP
BEIJNEN JH
ROZENDOM E
BULT A
UNDERBERG WJM
Citation: Gp. Kaijser et al., ANALYSIS OF IFOSFORAMIDE MUSTARD, THE ACTIVE METABOLITE OF IFOSFAMIDE, IN PLASMA, Journal of chromatography B. Biomedical applications, 686(2), 1996, pp. 249-255
Authors:
KAIJSER GP
BEIJNEN JH
KEIZER HJ
DEKRAKER J
BULT A
UNDERBERG WJM
Citation: Gp. Kaijser et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID, Journal of drug development and clinical practice, 7(4), 1996, pp. 319-326
Authors:
KAIJSER GP
KEIZER HJ
BEIJNEN JH
BULT A
UNDERBERG WJM
Citation: Gp. Kaijser et al., PHARMACOKINETICS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA AND URINE OF CANCER-PATIENTS TREATED WITHA 10-DAY CONTINUOUS-INFUSION OF IFOSFAMIDE, Anticancer research, 16(5B), 1996, pp. 3247-3257
Authors:
REUBSAET JLE
BEIJNEN JH
BOLT A
HOP E
VERMAAS R
KELLOKULE Y
VANDENBOSCH JJK
UNDERBERG WJM
Citation: Jle. Reubsaet et al., STRUCTURAL IDENTIFICATION OF THE DEGRADATION PRODUCTS OF THE ANTITUMOR PEPTIDE ANTAGONIST [ARG(6),D-TRP(7,9),MEPHE(8)]SUBSTANCE-P(6-11), Analytical chemistry, 67(23), 1995, pp. 4431-4436
Citation: Jle. Reubsaet et al., REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS IN THE STABILITY STUDY OF THE NEUROPEPTIDE GROWTH-FACTOR ANTAGONIST [ARG(6),D-TRP(7,9),MEPHE(8)]-SUBSTANCE-P(6-11) - A COMPARATIVE-STUDY, (VOL 220, PG 98, 1994), Analytical biochemistry, 225(2), 1995, pp. 379-380
Authors:
VANDERHOUWEN OAGJ
BEKERS O
BEIJNEN JH
BULT A
LUBBERS SCM
UNDERBERG WJM
Citation: Oagj. Vanderhouwen et al., DEGRADATION KINETICS OF THE INVESTIGATIONAL ANTITUMOR COMPOUND LL-D49194(ALPHA-1) IN THE PRESENCE OF BUFFERS, International journal of pharmaceutics, 112(1), 1994, pp. 97-101
Authors:
VANDERHOUWEN OAGJ
BEIJNEN JH
BULT A
UNDERBERG WJM
Citation: Oagj. Vanderhouwen et al., A GENERAL-APPROACH TO THE INTERPRETATION OF PH BUFFER CATALYZED DEGRADATION PROFILES, International journal of pharmaceutics, 109(3), 1994, pp. 191-196
Authors:
VANDERHOUWEN OAGJ
TEEUWSEN J
BEKERS O
BEIJNEN JH
BULT A
UNDERBERG WJM
Citation: Oagj. Vanderhouwen et al., DEGRADATION KINETICS OF 7-N-(P-HYDROXYPHENYL)MITOMYCIN-C (M-83) IN AQUEOUS-SOLUTION IN THE PRESENCE OF GAMMA-CYCLODEXTRIN, International journal of pharmaceutics, 105(3), 1994, pp. 249-254
Citation: Dm. Burger et al., SHORT-TERM, COMBINED USE OF PARACETAMOL AND ZIDOVUDINE DOES NOT ALTERTHE PHARMACOKINETICS OF EITHER DRUG, Netherlands journal of medicine, 44(5), 1994, pp. 161-165